Cytoreduction with Hyperthermic Intraperitoneal Chemotherapy and Renal Insufficiency Related to Diabetes Mellitus: An Anesthetic Challenge

Bartos, Adrian; Breazu, Caius; Bartos, Dana; Ciobanu, Lidia; Mitre, Calin

doi:10.1515/jccm-2017-0027

Abstract

Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) improves the prognosis in selected patients with peritoneal surface malignancies but it is an extensive procedure predisposing to major complications. Among them renal toxicity was reported. Severe renal insufficiency is considered a contraindication for this complex procedure. We present a patient with diabetic nephropathy with renal insufficiency KDOQI 3 and peritoneal metastasis from sigmoid adenocarcinoma with a good clinical outcome after CRS with HIPEC, highlighting the anesthetic precautions considered for this particular clinical case.

References

1. Esquivel J, Sticca R, Sugarbaker P, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann Surg Oncol. 2007;14:128-133.10.1245/s10434-006-9185-717072675
Open DOI Search in Google Scholar Back to article
2. Randle RW, Ahmed S, Levine EA, et al. Significance of diabetes on morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2015;111:740-745.10.1002/jso.23865440679725556634
Search in Google Scholar Back to article
3. Glehen O, Osinsky D, Cotte E, et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol. 2003;10:863-869.10.1245/ASO.2003.01.018
Search in Google Scholar Back to article
4. Verwaal VJ, van Tinteren H, Ruth SV, Zoetmulder FA. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol. 2004; 85: 61-67.10.1002/jso.2001314755505
Open DOI Search in Google Scholar Back to article
5. Kusamura S, Baratti D, Younan R, et al. Impact of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy on systemic toxicity. Ann Surg Oncol. 2007;14:2550-2558.10.1245/s10434-007-9429-117558537
Open DOI Search in Google Scholar Back to article
6. Cotte E, Passot G, Gilly FN, Glehen O. Selection of patients and staging of peritoneal surface malignancies. World J Gastrointest Oncol. 2010;2:31-35.10.4251/wjgo.v2.i1.31299915821160814
Search in Google Scholar Back to article
7. Ulusakarya A, Misra S, Haydar M, et al. Acute renal failure related to oxaliplatin-induced intravascular hemolysis. Med Oncol. 2010;27:1425-1426.10.1007/s12032-009-9263-319565364
Open DOI Search in Google Scholar Back to article
8. Puiac C, Szederjesi J, Lazar A, Bad C, Puscasiu L. Neutrophil Gelatinase-Associated Lipocalin as a Marker for Renal Dysfunction Detection in Critically Ill Patients with Increased Intraabdominal Pressure. J Crit Care Med. 2017;3(1):24-28.10.1515/jccm-2017-0006576989529967867
Search in Google Scholar Back to article
9. Corbella D, Piraccini E, Finazzi P, et al. Anesthetic management of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy procedures. World J Obstet Gynecol. 2013;2:129-13610.5317/wjog.v2.i4.129
Open DOI Search in Google Scholar Back to article
10. Esquivel J, Angulo F, Bland RK, Stephens AD, Sugarbaker PH. Hemodynamic and cardiac function parameters during heated intraoperative intraperitoneal chemotherapy using the open “coliseum technique”. Ann Surg Oncol. 2000;7:296-300.10.1007/s10434-000-0296-210819370
Search in Google Scholar Back to article
11. Christophi C, Winkworth A, Muralihdaran V, Evans P. The treatment of malignancy by hyperthermia. Surg Oncol. 1998;7:83-90.10.1016/S0960-7404(99)00007-9
Open DOI Search in Google Scholar Back to article
12. Miao N, Pingpank JF, Alexander HR, et al. Cytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: hemodynamic, metabolic, and anesthetic considerations. Ann Surg Oncol. 2009;16:334-344.10.1245/s10434-008-0253-z263746819050961
Open DOI Search in Google Scholar Back to article
13. Raue W, Tsilimparis N, Bloch A, Menenakos C, Hartmann J. Volume therapy and cardiocircular function during hyperthermic intraperitoneal chemotherapy. Eur Surg Res. 2009;43:365-372.10.1159/00024816419844110
Search in Google Scholar Back to article
14. Cafiero T, Di Iorio C, Di Minno RM, Sivolella G, Confuorto G. Non-invasive cardiac monitoring by aortic blood flow determination in patients undergoing hyperthermic intraperitoneal intraoperative chemotherapy. Minerva Anestesiol. 2006;72:207-215.
Search in Google Scholar Back to article

Cytoreduction with Hyperthermic Intraperitoneal Chemotherapy and Renal Insufficiency Related to Diabetes Mellitus: An Anesthetic Challenge

Abstract

Paradigm

My account